NEW YORK, April 26 - Celera said Thursday its third-quarter fiscal 2001 revenues rose to $23.4 million, from $11.1 million in the year-ago period, as the company continued to add subscribers to its database and to initiate new collaborations.

This quarter’s doubling in revenues over the previous year’s quarter continued a trend that began in Celera’s first fiscal quarter. With this continued upsurge, Celera said it was still on track to double its revenues by the end of the year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.